ketamine has been researched along with Ileus in 2 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Ileus: A condition caused by the lack of intestinal PERISTALSIS or INTESTINAL MOTILITY without any mechanical obstruction. This interference of the flow of INTESTINAL CONTENTS often leads to INTESTINAL OBSTRUCTION. Ileus may be classified into postoperative, inflammatory, metabolic, neurogenic, and drug-induced.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketamine did not prevent LPS induced gastrointestinal ileus, nor did it improve gastric emptying." | 3.73 | Ketamine inhibits lipopolysacharide (LPS) induced gastric luminal fluid accumulation. ( Gonzalez, EA; Mercer, DW; Moore, FA; Moore-Olufemi, SD; Suliburk, JW; Weisbrodt, N, 2005) |
| "Ketamine is a hypnotic pharmacon with high analgesic potency." | 1.33 | [Intravenous S-+-ketamine for treatment of visceral pain in the final phase]. ( Hartmann, W; Weixler, D, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suliburk, JW | 1 |
| Gonzalez, EA | 1 |
| Moore-Olufemi, SD | 1 |
| Weisbrodt, N | 1 |
| Moore, FA | 1 |
| Mercer, DW | 1 |
| Weixler, D | 1 |
| Hartmann, W | 1 |
2 other studies available for ketamine and Ileus
| Article | Year |
|---|---|
Ketamine inhibits lipopolysacharide (LPS) induced gastric luminal fluid accumulation.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Body Fluids; Gastric Emptying; Gastric Mucosa; | 2005 |
[Intravenous S-+-ketamine for treatment of visceral pain in the final phase].
Topics: Abdominal Pain; Adenocarcinoma; Analgesics; Cecal Neoplasms; Dose-Response Relationship, Drug; Drug | 2006 |